1887

Journal of Medical Microbiology logo

Volume 64, Issue 2

Probiotics or antibiotics: future challenges in medicine Free

Abstract

Genetic and environmental factors can affect the intestinal microbiome and microbial metabolome. Among these environmental factors, the consumption of antibiotics can significantly change the intestinal microbiome of individuals and consequently affect the corresponding metagenome. The term ‘probiotics’ is related to preventive medicine rather than therapeutic procedures and is, thus, considered the opposite of antibiotics. This review discusses the challenges between these opposing treatments in terms of the following points: (i) antibiotic resistance, the relationship between antibiotic consumption and microbiome diversity reduction, antibiotic effect on the metagenome, and disease associated with antibiotics; and (ii) probiotics as living drugs, probiotic effect on epigenetic alterations, and gut microbiome relevance to hygiene indulgence. The intestinal microbiome is more specific for individuals and may be affected by environmental alterations and the occurrence of diseases.

  • Published Online:
© 2015 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.078923-0
2015-02-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/2/137.html?itemId=/content/journal/jmm/10.1099/jmm.0.078923-0&mimeType=html&fmt=ahah

References

  1. Abel T., Zukin R. S. 2008; Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 8:57–64 [View Article][PubMed]
     [Google Scholar]
  2. Al-Nassir W. N., Sethi A. K., Li Y., Pultz M. J., Riggs M. M., Donskey C. J. 2008; Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob Agents Chemother 52:2403–2406 [View Article][PubMed]
     [Google Scholar]
  3. Bach J.-F., Chatenoud L. 2012; The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes. Cold Spring Harb Perspect Med 2:a007799 [View Article][PubMed]
     [Google Scholar]
  4. Barc M.-C., Charrin-Sarnel C., Rochet V., Bourlioux F., Sandré C., Boureau H., Doré J., Collignon A. 2008; Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: influence of Saccharomyces boulardii . Anaerobe 14:229–233 [View Article][PubMed]
     [Google Scholar]
  5. Bastow R., Mylne J. S., Lister C., Lippman Z., Martienssen R. A., Dean C. 2004; Vernalization requires epigenetic silencing of FLC by histone methylation. Nature 427:164–167 [View Article][PubMed]
     [Google Scholar]
  6. Belda-Ferre P., Alcaraz L. D., Cabrera-Rubio R., Romero H., Simón-Soro A., Pignatelli M., Mira A. 2012; The oral metagenome in health and disease. ISME J 6:46–56 [View Article][PubMed]
     [Google Scholar]
  7. Blaut M., Bischoff S. C. 2010; Probiotics and obesity. Ann Nutr Metab 57:Suppl.20–23 [View Article][PubMed]
     [Google Scholar]
  8. Botina S. G., Poluéktova E. U., Glazkova A. A., Zakharevich N. V., Koroban N. V., Zinchenko V. V., Babykin M. M., Zhilenkova O. G., Amerkhanova A. M., Danilenko V. N. 2011; [Antibiotic resistance of potential probiotic bacteria of the genus Lactobacillus from human gastrointestinal microbiome]. Mikrobiologiia 80:175–183 (in Russian) [PubMed]
     [Google Scholar]
  9. Bouton Y., Guyot P., Beuvier E., Tailliez P., Grappin R. 2002; Use of PCR-based methods and PFGE for typing and monitoring homofermentative lactobacilli during Comté cheese ripening. Int J Food Microbiol 76:27–38 [View Article][PubMed]
     [Google Scholar]
  10. Butler C. C., Duncan D., Hood K. 2012; Does taking probiotics routinely with antibiotics prevent antibiotic associated diarrhoea?. BMJ 344:e682 [View Article][PubMed]
     [Google Scholar]
  11. Canani R. B., Di Costanzo M., Leone L., Bedogni G., Brambilla P., Cianfarani S., Nobili V., Pietrobelli A., Agostoni C. 2011; Epigenetic mechanisms elicited by nutrition in early life. Nutr Res Rev 24:198–205 [View Article][PubMed]
     [Google Scholar]
  12. Carlet J. 2012; The gut is the epicentre of antibiotic resistance. Antimicrob Resist Infect Control 1:39 [View Article][PubMed]
     [Google Scholar]
  13. Cars O., Högberg L. D., Murray M., Nordberg O., Sivaraman S., Lundborg C. S., So A. D., Tomson G. 2008; Meeting the challenge of antibiotic resistance. BMJ 337:a1438 [View Article][PubMed]
     [Google Scholar]
  14. Castanon J. I. 2007; History of the use of antibiotic as growth promoters in European poultry feeds. Poult Sci 86:2466–2471 [View Article][PubMed]
     [Google Scholar]
  15. Cheng Q., Wang S., Salyers A. A. 2003; New approaches for anti-infective drug discovery: antibiotics, vaccines and beyond. Curr Drug Targets Infect Disord 3:65–75 [View Article][PubMed]
     [Google Scholar]
  16. Cimperman L., Bayless G., Best K., Diligente A., Mordarski B., Oster M., Smith M., Vatakis F., Wiese D. et al. 2011; A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol 45:785–789 [View Article][PubMed]
     [Google Scholar]
  17. Climo M. W., Sepkowitz K. A., Zuccotti G., Fraser V. J., Warren D. K., Perl T. M., Speck K., Jernigan J. A., Robles J. R., Wong E. S. 2009; The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 37:1858–1865 [View Article][PubMed]
     [Google Scholar]
  18. Collado M. C., Cernada M., Baüerl C., Vento M., Pérez-Martínez G. 2012; Microbial ecology and host-microbiota interactions during early life stages. Gut Microbes 3:352–365 [View Article][PubMed]
     [Google Scholar]
  19. Correa N. B., Peret Filho L. A., Penna F. J., Lima F. M., Nicoli J. R. 2005; A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. Journal of clinical gastroenterology 39:385–389 [CrossRef]
     [Google Scholar]
  20. Costelloe C., Metcalfe C., Lovering A., Mant D., Hay A. D. 2010; Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340:c2096 [View Article][PubMed]
     [Google Scholar]
  21. Damaskos D., Kolios G. 2008; Probiotics and prebiotics in inflammatory bowel disease: microflora ‘on the scope’. Br J Clin Pharmacol 65:453–467 [View Article][PubMed]
     [Google Scholar]
  22. Dancer S. J. 2008; The effect of antibiotics on methicillin-resistant Staphylococcus aureus . J Antimicrob Chemother 61:246–253 [View Article][PubMed]
     [Google Scholar]
  23. Delcenserie V., Martel D., Lamoureux M., Amiot J., Boutin Y., Roy D. 2008; Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol 10:37–54[PubMed]
     [Google Scholar]
  24. Dethlefsen L., Huse S., Sogin M. L., Relman D. A. 2008; The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6:e280 [View Article][PubMed]
     [Google Scholar]
  25. Dinleyici E. C., Eren M., Ozen M., Yargic Z. A., Vandenplas Y. 2012; Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 12:395–410 [View Article][PubMed]
     [Google Scholar]
  26. Ellison R. T. III 2006; Review: probiotics are effective for prevention of antibiotic-associated diarrhea and treatment of Clostridium difficile disease. ACP J Club 145:46[PubMed]
     [Google Scholar]
  27. Engelbrektson A. L., Korzenik J. R., Sanders M. E., Clement B. G., Leyer G., Klaenhammer T. R., Kitts C. L. 2006; Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiol Ecol 57:239–250 [View Article][PubMed]
     [Google Scholar]
  28. Fey P. D., Safranek T. J., Rupp M. E., Dunne E. F., Ribot E., Iwen P. C., Bradford P. A., Angulo F. J., Hinrichs S. H. 2000; Ceftriaxone-resistant salmonella infection acquired by a child from cattle. N Engl J Med 342:1242–1249 [View Article][PubMed]
     [Google Scholar]
  29. Fouhy F., Guinane C. M., Hussey S., Wall R., Ryan C. A., Dempsey E. M., Murphy B., Ross R. P., Fitzgerald G. F. et al. 2012; High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 56:5811–5820 [View Article][PubMed]
     [Google Scholar]
  30. Friedman G. 2012; The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium difficile colitis. Gastroenterol Clin North Am 41:763–779 [View Article][PubMed]
     [Google Scholar]
  31. Fuller R. 1989; Probiotics in man and animals. The Journal of applied bacteriology 66:365–378 [CrossRef]
     [Google Scholar]
  32. Garcia-Mazcorro J. F., Lanerie D. J., Dowd S. E., Paddock C. G., Grützner N., Steiner J. M., Ivanek R., Suchodolski J. S. 2011; Effect of a multi-species synbiotic formulation on fecal bacterial microbiota of healthy cats and dogs as evaluated by pyrosequencing. FEMS Microbiol Ecol 78:542–554 [View Article][PubMed]
     [Google Scholar]
  33. Gilchrist M., Winyard P. G., Benjamin N. 2010; Dietary nitrate – good or bad?. Nitric Oxide 22:104–109 [View Article][PubMed]
     [Google Scholar]
  34. Gill H., Prasad J. 2008; Probiotics, immunomodulation, and health benefits. In Bioactive Components of Milk pp. 423–454 Edited by Bösze Z. New York: Springer; [View Article]
     [Google Scholar]
  35. Gluckman P. D., Hanson M. A. 2008; Developmental and epigenetic pathways to obesity: an evolutionary-developmental perspective. Int J Obes (Lond) 32:Suppl. 7S62–S71 [View Article][PubMed]
     [Google Scholar]
  36. Glynn M. K., Bopp Ch., Dewitt W., Dabney P., Mokhtar M., Angulo F. J. 1998; Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States. N Engl J Med 338:1333–1338 [View Article][PubMed]
     [Google Scholar]
  37. Goldin B. R., Gorbach S. L. 2008; Clinical indications for probiotics: an overview. Clin Infect Dis 46:Suppl. 2S96–S100 [View Article][PubMed]
     [Google Scholar]
  38. Guarner F., Bourdet-Sicard R., Brandtzaeg P., Gill H. S., McGuirk P., van Eden W., Versalovic J., Weinstock J. V., Rook G. A. W. 2006; Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 3:275–284 [View Article][PubMed]
     [Google Scholar]
  39. Gueimonde M., Collado M. C. 2012; Metagenomics and probiotics. Clin Microbiol Infect 18:Suppl. 432–34 [View Article][PubMed]
     [Google Scholar]
  40. Hammad A. M., Shimamoto T. 2010; Towards a compatible probiotic-antibiotic combination therapy: assessment of antimicrobial resistance in the Japanese probiotics. J Appl Microbiol 109:1349–1360 [View Article][PubMed]
     [Google Scholar]
  41. Hattori M., Taylor T. D. 2009; The human intestinal microbiome: a new frontier of human biology. DNA Res 16:1–12 [View Article][PubMed]
     [Google Scholar]
  42. Hoveyda N., Heneghan C., Mahtani K. R., Perera R., Roberts N., Glasziou P. 2009; A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 9:15 [View Article][PubMed]
     [Google Scholar]
  43. Iacobuzio-Donahue C. A. 2009; Epigenetic changes in cancer. Annu Rev Pathol 4:229–249 [View Article][PubMed]
     [Google Scholar]
  44. Jakobsson H. E., Jernberg C., Andersson A. F., Sjölund-Karlsson M., Jansson J. K., Engstrand L. 2010; Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 5:e9836 [View Article][PubMed]
     [Google Scholar]
  45. Jia W., Li H., Zhao L., Nicholson J. K. 2008; Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov 7:123–129 [View Article][PubMed]
     [Google Scholar]
  46. Johnson C. L., Versalovic J. 2012; The human microbiome and its potential importance to pediatrics. Pediatrics 129:950–960 [View Article][PubMed]
     [Google Scholar]
  47. Kazimierczak K. A., Scott K. P. 2007; Antibiotics and resistance genes: influencing the microbial ecosystem in the gut. Adv Appl Microbiol 62:269–292 [View Article][PubMed]
     [Google Scholar]
  48. Kho H.-S., Park M.-S., Chang J.-Y., Kim Y.-Y. 2014; Yam tuber mucilage as a candidate substance for saliva substitute: in vitro study of its viscosity and influences on lysozyme and peroxidase activities. Gerodontology 31:34–41 [View Article][PubMed]
     [Google Scholar]
  49. Kinross J. M., Darzi A. W., Nicholson J. K. 2011; Gut microbiome-host interactions in health and disease. Genome Med 3:14 [View Article][PubMed]
     [Google Scholar]
  50. Kuitunen M., Kukkonen K., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., Haahtela T., Savilahti E. 2009; Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 123:335–341 [View Article][PubMed]
     [Google Scholar]
  51. Kuitunen M., Kukkonen A. K., Savilahti E. 2012; Impact of maternal allergy and use of probiotics during pregnancy on breast milk cytokines and food antibodies and development of allergy in children until 5 years. Int Arch Allergy Immunol 159:162–170 [View Article][PubMed]
     [Google Scholar]
  52. Kumar M., Nagpal R., Verma V., Kumar A., Kaur N., Hemalatha R., Gautam S. K., Singh B. 2013; Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr Rev 71:23–34 [View Article][PubMed]
     [Google Scholar]
  53. Lodise T. P., Graves J., Evans A., Graffunder E., Helmecke M., Lomaestro B. M., Stellrecht K. 2008; Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 52:3315–3320 [View Article][PubMed]
     [Google Scholar]
  54. Lönnermark E., Friman V., Lappas G., Sandberg T., Berggren A., Adlerberth I. 2010; Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol 44:106–112 [View Article][PubMed]
     [Google Scholar]
  55. Looft T., Allen H. K. 2012; Collateral effects of antibiotics on mammalian gut microbiomes. Gut Microbes 3:463–467 [View Article][PubMed]
     [Google Scholar]
  56. McFarland L. V. 2008; Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol 3:563–578 [View Article][PubMed]
     [Google Scholar]
  57. Merenstein D., Murphy M., Fokar A., Hernandez R. K., Park H., Nsouli H., Sanders M. E., Davis B. A., Niborski V. et al. 2010; Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr 64:669–677 [View Article][PubMed]
     [Google Scholar]
  58. Mikelsaar M. 2011; Human microbial ecology: lactobacilli, probiotics, selective decontamination. Anaerobe 17:463–467 [View Article][PubMed]
     [Google Scholar]
  59. Mikelsaar M., Lazar V., Onderdonk A., Donelli G. 2011; Do probiotic preparations for humans really have efficacy?. Microb Ecol Health Dis 22:10128 [View Article]
     [Google Scholar]
  60. Nakao M. 2001; Epigenetics: interaction of DNA methylation and chromatin. Gene 278:25–31 [View Article][PubMed]
     [Google Scholar]
  61. Nayak S. K., Mukherjee S. C. 2011; Screening of gastrointestinal bacteria of Indian major carps for a candidate probiotic species for aquaculture practices. Aquacult Res 42:1034–1041 [View Article]
     [Google Scholar]
  62. Ogué-Bon E., Khoo C., Hoyles L., McCartney A. L., Gibson G. R., Rastall R. A. 2011; In vitro fermentation of rice bran combined with Lactobacillus acidophilus 14 150B or Bifidobacterium longum 05 by the canine faecal microbiota. FEMS Microbiol Ecol 75:365–376 [View Article][PubMed]
     [Google Scholar]
  63. Ogunshe A. A. 2008; Effect of production batches of antibiotics on in vitro selection criterion for potential probiotic candidates. J Med Food 11:753–760 [View Article][PubMed]
     [Google Scholar]
  64. Okada H., Kuhn C., Feillet H., Bach J. F. 2010; The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update. Clin Exp Immunol 160:1–9 [View Article][PubMed]
     [Google Scholar]
  65. Ordovás J. M., Smith C. E. 2010; Epigenetics and cardiovascular disease. Nat Rev Cardiol 7:510–519 [View Article][PubMed]
     [Google Scholar]
  66. Orman B. E., Piñeiro S. A., Arduino S., Galas M., Melano R., Caffer M. I., Sordelli D. O., Centrón D. 2002; Evolution of multiresistance in nontyphoid Salmonella serovars from 1984 to 1998 in Argentina. Antimicrob Agents Chemother 46:3963–3970 [View Article][PubMed]
     [Google Scholar]
  67. Oudhuis G. J., Bergmans D. C., Dormans T., Zwaveling J. H., Kessels A., Prins M. H., Stobberingh E. E., Verbon A. 2011; Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality. Intensive Care Med 37:110–117 [View Article][PubMed]
     [Google Scholar]
  68. Park J. H., Stoffers D. A., Nicholls R. D., Simmons R. A. 2008; Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest 118:2316–2324[PubMed]
     [Google Scholar]
  69. Pérez-Cobas A. E., Gosalbes M. J., Friedrichs A., Knecht H., Artacho A., Eismann K., Otto W., Rojo D., Bargiela R. et al. 2013; Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 62:1591–1601 [View Article][PubMed]
     [Google Scholar]
  70. Peterson D. A., Frank D. N., Pace N. R., Gordon J. I. 2008; Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 3:417–427 [View Article][PubMed]
     [Google Scholar]
  71. Porsby C. H., Webber M. A., Nielsen K. F., Piddock L. J., Gram L. 2011; Resistance and tolerance to tropodithietic acid, an antimicrobial in aquaculture, is hard to select. Antimicrob Agents Chemother 55:1332–1337 [View Article][PubMed]
     [Google Scholar]
  72. Prantera C., Scribano M. L. 2009; Antibiotics and probiotics in inflammatory bowel disease: why, when, and how. Curr Opin Gastroenterol 25:329–333 [View Article][PubMed]
     [Google Scholar]
  73. Preidis G. A., Versalovic J. 2009; Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136:2015–2031 [View Article][PubMed]
     [Google Scholar]
  74. Prescott J. F. 2008; Antimicrobial use in food and companion animals. Anim Health Res Rev 9:127–133 [View Article][PubMed]
     [Google Scholar]
  75. Quigley E. M. 2011; Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Gastroenterol Clin North Am 40:207–222 [View Article][PubMed]
     [Google Scholar]
  76. Rajender S., Avery K., Agarwal A. 2011; Epigenetics, spermatogenesis and male infertility. Mutat Res 727:62–71 [View Article][PubMed]
     [Google Scholar]
  77. Reid G., Dols J., Miller W. 2009; Targeting the vaginal microbiota with probiotics as a means to counteract infections. Curr Opin Clin Nutr Metab Care 12:583–587 [View Article][PubMed]
     [Google Scholar]
  78. Riboulet-Bisson E., Sturme M. H., Jeffery I. B., O’Donnell M. M., Neville B. A., Forde B. M., Claesson M. J., Harris H., Gardiner G. E. et al. 2012; Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota. PLoS ONE 7:e31113 [View Article][PubMed]
     [Google Scholar]
  79. Riddle D. J., Dubberke E. R. 2009; Clostridium difficile infection in the intensive care unit. Infect Dis Clin North Am 23:727–743 [View Article][PubMed]
     [Google Scholar]
  80. Ruszczyński M., Radzikowski A., Szajewska H. 2008; Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther 28:154–161 [View Article][PubMed]
     [Google Scholar]
  81. Scherer A., Vogt H. R., Vilei E. M., Frey J., Perreten V. 2013; Enhanced antibiotic multi-resistance in nasal and faecal bacteria after agricultural use of streptomycin. Environ Microbiol 15:297–304 [View Article][PubMed]
     [Google Scholar]
  82. Sengupta R., Altermann E., Anderson R. C., McNabb W. C., Moughan P. J., Roy N. C. 2013; The role of cell surface architecture of lactobacilli in host-microbe interactions in the gastrointestinal tract. Mediators Inflamm 2013:237921 [View Article][PubMed]
     [Google Scholar]
  83. Shadnoush M., Shaker Hosseini R., Mehrabi Y., Delpisheh A., Alipoor E., Faghfoori Z., Mohammadpour N., Zaringhalam Moghadam J. 2013; Probiotic yogurt affects pro- and anti-inflammatory factors in patients with inflammatory bowel disease. Iran J Pharm Res 12:929–936[PubMed]
     [Google Scholar]
  84. Sievert D. M., Rudrik J. T., Patel J. B., McDonald L. C., Wilkins M. J., Hageman J. C. 2008; Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 46:668–674 [View Article][PubMed]
     [Google Scholar]
  85. Siew-Wai L., Zi-Ni T., Karim A. A., Hani N. M., Rosma A. 2010; Fermentation of Metroxylon sagu resistant starch type III by Lactobacillus sp. and Bifidobacterium bifidum . J Agric Food Chem 58:2274–2278 [View Article][PubMed]
     [Google Scholar]
  86. Smith T. C., Male M. J., Harper A. L., Kroeger J. S., Tinkler G. P., Moritz E. D., Capuano A. W., Herwaldt L. A., Diekema D. J. 2009; Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workers. PLoS ONE 4:e4258 [View Article][PubMed]
     [Google Scholar]
  87. Snydman D. R. 2008; The safety of probiotics. Clin Infect Dis 46:Suppl. 2S104–S111 [View Article][PubMed]
     [Google Scholar]
  88. Teran C. G., Teran-Escalera C. N., Villarroel P. 2009; Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children. Int J Infect Dis 13:518–523 [View Article][PubMed]
     [Google Scholar]
  89. Tuohy K. M., Gougoulias C., Shen Q., Walton G., Fava F., Ramnani P. 2009; Studying the human gut microbiota in the trans-omics era–focus on metagenomics and metabonomics. Curr Pharm Des 15:1415–1427 [View Article][PubMed]
     [Google Scholar]
  90. Turpin W., Humblot C., Guyot J. P. 2011; Genetic screening of functional properties of lactic acid bacteria in a fermented pearl millet slurry and in the metagenome of fermented starchy foods. Appl Environ Microbiol 77:8722–8734 [View Article][PubMed]
     [Google Scholar]
  91. Ventura M., Turroni F., Canchaya C., Vaughan E. E., O’Toole P. W., van Sinderen D. 2009; Microbial diversity in the human intestine and novel insights from metagenomics. Front Biosci (Landmark Ed) 14:3214–3221 [View Article][PubMed]
     [Google Scholar]
  92. Yazdanbakhsh M., Kremsner P. G., van Ree R. 2002; Allergy, parasites, and the hygiene hypothesis. Science 296:490–494 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.078923-0
Loading

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error